1. Search Result
Search Result
Results for "

2489390-15-8

" in MCE Product Catalog:
Cat. No. Product Name Target Research Area
  • HY-P99431
    KY-1044

    Alomfilimab; SAR 445256

    Inhibitory Antibodies Cancer Inflammation/Immunology
    KY-1044 (Alomfilimab; SAR 445256) is a fully human IgG1 antibody targeting inducible costimulatory receptor (ICOS). KY-1044 depletes ICOS high cells via antibody-dependent cellular cytotoxicity (ADCC) through the engagement of FcgRIIIa. KY-1044 act as a costimulatory molecule on cells expressing lower ICOS levels, such as CD8 + TEff cells (through FcgR-dependent clustering). KY-1044 exploit the differential expression of ICOS on T-cell subtypes to improve the intratumoral immune contexture and restore an antitumor immune response.